Nektar Therapeutics Earnings
NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-2.20
Nektar Therapeutics earnings summary
Nektar Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-2.20. In its most recent report on Aug 14, 2026 (Q2 2026), NKTR posted EPS of $-1.23. Revenue for the quarter was $10.1 million.
Across the last 16 reports, NKTR shares moved an average of 10.4% (in either direction) in the first trading session after results, rising 7 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
NKTR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 14, 2026 | — | $-1.23 | — | +1.4% |
| May 8, 2026 | — | $-1.82 | — | -13.8% |
| Mar 13, 2026 | — | $-1.29 | — | -1.4% |
| Nov 7, 2025 | — | $-1.87 | — | +1.3% |
| Aug 8, 2025 | — | $-2.95 | — | +18.2% |
| May 9, 2025 | — | $-3.62 | — | +16.9% |
| Mar 14, 2025 | — | $-2.07 | — | -4.4% |
| Nov 8, 2024 | — | $-2.66 | — | -23.6% |
| Aug 9, 2024 | — | $-3.76 | — | +12.6% |
| May 10, 2024 | — | $-0.19 | — | 0.0% |
| Mar 5, 2024 | — | $-0.21 | — | -5.5% |
| Nov 8, 2023 | — | $-0.24 | — | +6.7% |
| Aug 9, 2023 | — | $-0.27 | — | -21.5% |
| May 10, 2023 | — | $-0.73 | — | -1.4% |
| Feb 28, 2023 | — | $-0.32 | — | -24.2% |
| Nov 4, 2022 | — | $-0.31 | — | +13.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.